|
Volumn 76, Issue 2, 2009, Pages 67-68
|
Toward standardization of FoxP3+ regulatory T-cell measurement in clinical settings
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEPARIN;
TRANSCRIPTION FACTOR FOXP3;
ANTICOAGULANT THERAPY;
CANCER IMMUNOTHERAPY;
CELL DIFFERENTIATION;
CELL FUNCTION;
CELL ISOLATION;
CELL POPULATION;
CULTURE TECHNIQUE;
CYTOMETRY;
EDITORIAL;
FLOW CYTOMETRY;
GRAFT VERSUS HOST REACTION;
GRAFT VERSUS LEUKEMIA EFFECT;
HUMAN;
IMMUNOLOGICAL TOLERANCE;
IMMUNOPHENOTYPING;
MOLECULAR PROBE;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
QUANTITATIVE ANALYSIS;
REGULATORY T LYMPHOCYTE;
STANDARDIZATION;
VALIDATION PROCESS;
ANIMALS;
CRYOPRESERVATION;
FLOW CYTOMETRY;
FORKHEAD TRANSCRIPTION FACTORS;
HUMANS;
IMMUNOPHENOTYPING;
IMMUNOSUPPRESSION;
SELF TOLERANCE;
STAINING AND LABELING;
STEM CELL TRANSPLANTATION;
T-LYMPHOCYTES, REGULATORY;
TISSUE FIXATION;
|
EID: 66249113560
PISSN: 15524949
EISSN: 15524957
Source Type: Journal
DOI: 10.1002/cyto.b.20471 Document Type: Editorial |
Times cited : (4)
|
References (8)
|